Mind Cure Announces Non-Brokered Private Placement of $3 Million
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin
Ryan Allway November 15th, 2020 Psychedelics Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on its oral thin-film delivery system with... Read more
Havn Life Announces Launch of a Range of Natural Health Products
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor
Ryan Allway November 15th, 2020 Psychedelics Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce the appointment of Dr. Alberto J. Espay, MD, MSc,... Read more
Psyched Wellness Ltd. Applied to Up-List to the OTCQB and DTC Eligibility
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
NeonMind Obtains Health Canada Approval to Advance Psilocybin Research
Vancouver, British Columbia–(Newsfile Corp. – November 12, 2020) –  Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant“) or (the “Company“) is pleased to announce that its majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind“) has obtained Health Canada approval to advance its preclinical trial on psilocybin-based... Read more
Red Light Holland to Acquire Wholesale Distribution Company in the Netherlands Providing Access to over 1,000 Retail Outlets in Multiple EU Countries
Ryan Allway November 11th, 2020 Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – November 10, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), is pleased to announce it has entered into a non-binding letter of intent to acquire SR Wholesale... Read more
Cybin Goes Public on the NEO Exchange
Ryan Allway November 10th, 2020 Psychedelics NEO is excited to announce that Cybin Inc.. (“Cybin”), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, has made its debut on the global public markets today. Cybin is now trading on the NEO Exchange under the symbol NEO:CYBN. Having recently closed Canada’s largest... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )